Zynerba Pharmaceuticals Inc reports Q2 results and provides

Zynerba Pharmaceuticals (NASDAQ:ZYNE) Inc has reported financial results for the second quarter ended June 30, 2022, and provided an overview of its recent...

Related Keywords

Armando Anido , Zynerba Pharmaceuticals , Drug Administration , New Drug Application , Fragilex Conference , American Society , Clinical Psychopharmacology Annual Meeting , Social Avoidance , Autism Spectrum Disorder ,